{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:10:51Z","timestamp":1789013451440,"version":"build-2803163510"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Top-level Talents Support Program of Yangzhou University","award":["Top-level Talents Support Program of Yangzhou University"],"award-info":[{"award-number":["Top-level Talents Support Program of Yangzhou University"]}]},{"name":"\u201cLv Yang Jin Feng\u201d Outstanding Doctor of Yangzhou","award":["\u201cLv Yang Jin Feng\u201d Outstanding Doctor of Yangzhou"],"award-info":[{"award-number":["\u201cLv Yang Jin Feng\u201d Outstanding Doctor of Yangzhou"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240907"],"award-info":[{"award-number":["BK20240907"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The blood-brain barrier (BBB) is a dynamic, multicellular interface that preserves central nervous system (CNS) homeostasis by restricting entry of pathogens and circulating cells. Cytotoxic T lymphocytes (CTLs), comprising both CD8\u207a and CD4\u207a subsets, are central to adaptive immunity through targeted elimination of infected or transformed cells. However, in immune-mediated neurological disorders, including viral encephalitis, multiple sclerosis, Parkinson\u2019s disease, and glioma, CTLs effector functions can inadvertently compromise BBB integrity. Here, we integrate findings from primary research to delineate three principal mechanisms by which CTLs modulate the BBB: (1) direct cytotoxicity, in which perforin\/granzyme release and FasL-Fas interactions induce endothelial cell apoptosis; (2) proinflammatory cytokine signaling, notably IFN\u2011\u03b3 and TNF\u2011\u03b1 activation of JAK\/STAT and NF\u2011\u03baB pathways in brain microvascular endothelial cells; and (3) chemokine\u2011driven leukocyte trafficking, wherein CXCL10 and CCL5 gradients promote CTLs and bystander immune cell migration across the barrier. We further review evidence from in vitro and in vivo models that illustrate both protective and deleterious roles of CTLs at the neurovascular interface. By clearly specifying these mechanisms and their disease\u2011specific contexts, this review establishes a unified framework for future investigations aimed at preserving BBB function while maintaining effective CTL\u2011mediated immunity.<\/jats:p>","DOI":"10.1186\/s12967-025-07288-3","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T07:03:38Z","timestamp":1766473418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytotoxic T lymphocytes and their dual role in modulating blood-brain barrier integrity in immune-mediated neurological pathologies"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-7512","authenticated-orcid":false,"given":"Bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"7288_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-Brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378.","journal-title":"Physiol Rev"},{"key":"7288_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbi.2022.09.002","volume":"106","author":"J Huang","year":"2022","unstructured":"Huang J, Ding J, Wang X, Gu C, He Y, Li Y, Fan H, Xie Q, Qi X, Wang Z, Qiu P. Transfer of neuron-derived alpha-synuclein to astrocytes induces neuroinflammation and blood-brain barrier damage after methamphetamine exposure: involving the regulation of nuclear receptor-associated protein 1. Brain Behav Immun. 2022;106:247\u201361.","journal-title":"Brain Behav Immun"},{"key":"7288_CR3","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1111\/cns.14292","volume":"29","author":"W Hou","year":"2023","unstructured":"Hou W, Yao J, Liu J, Lin X, Wei J, Yin X, Huang H, Chen X, Yang GY, He X. USP14 Inhibition promotes recovery by protecting BBB integrity and attenuating neuroinflammation in MCAO mice. CNS Neurosci Ther. 2023;29:3612\u201323.","journal-title":"CNS Neurosci Ther"},{"key":"7288_CR4","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1038\/s41467-023-38703-2","volume":"14","author":"S Aydin","year":"2023","unstructured":"Aydin S, Pareja J, Schallenberg VM, Klopstein A, Gruber T, Page N, Bouillet E, Blanchard N, Liblau R, Korbelin J, et al. Antigen recognition detains CD8(+) T cells at the blood-brain barrier and contributes to its breakdown. Nat Commun. 2023;14:3106.","journal-title":"Nat Commun"},{"key":"7288_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-023-02797-8","volume":"20","author":"S Soldati","year":"2023","unstructured":"Soldati S, Bar A, Vladymyrov M, Glavin D, McGrath JL, Gosselet F, Nishihara H, Goelz S, Engelhardt B. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4(+) T cell arrest on the inflamed BBB under flow in vitro. J Neuroinflammation. 2023;20:123.","journal-title":"J Neuroinflammation"},{"key":"7288_CR6","doi-asserted-by":"publisher","first-page":"106290","DOI":"10.1016\/j.nbd.2023.106290","volume":"187","author":"JJ Ahn","year":"2023","unstructured":"Ahn JJ, Islam Y, Clarkson-Paredes C, Karl MT, Miller RH. B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis. Neurobiol Dis. 2023;187:106290.","journal-title":"Neurobiol Dis"},{"key":"7288_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and damps: signal 0s that spur autophagy and immunity. Immunol Rev. 2012;249:158\u201375.","journal-title":"Immunol Rev"},{"key":"7288_CR8","doi-asserted-by":"publisher","first-page":"840610","DOI":"10.3389\/fimmu.2022.840610","volume":"13","author":"JA Wik","year":"2022","unstructured":"Wik JA, Skalhegg BS. T cell metabolism in infection. Front Immunol. 2022;13:840610.","journal-title":"Front Immunol"},{"key":"7288_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11882-014-0434-8","volume":"14","author":"H Eibel","year":"2014","unstructured":"Eibel H, Kraus H, Sic H, Kienzler AK, Rizzi M. B cell biology: an overview. Curr Allergy Asthma Rep. 2014;14:434.","journal-title":"Curr Allergy Asthma Rep"},{"key":"7288_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman NM, Boothby MR, Chi H. Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol. 2020;20:55\u201370.","journal-title":"Nat Rev Immunol"},{"key":"7288_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217.","journal-title":"Signal Transduct Target Ther"},{"key":"7288_CR12","doi-asserted-by":"publisher","first-page":"147937","DOI":"10.1016\/j.brainres.2022.147937","volume":"1788","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Gan L, Ren L, Lin Y, Ma C, Lin X. Factors influencing the blood-brain barrier permeability. Brain Res. 2022;1788:147937.","journal-title":"Brain Res"},{"key":"7288_CR13","unstructured":"Ehrlich P. Das Sauerstoff-Bed\u00fcrfniss des organismus: eine Farbenanalytische studie. A. Hirschwald. 1885."},{"key":"7288_CR14","unstructured":"Goldmann EE. Die \u00e4ussere und innere skeretion des Gesunden organismus Im lichte der Vitalen F\u00e4rbung. H. Laupp\u2019schen Buchhandlung. 1909."},{"key":"7288_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/13813452109146211","volume":"17","author":"L Stern","year":"1921","unstructured":"Stern L, Gautier R. Recherches Sur Le Liquide c\u00e9phalo-rachidien: I.\u2013Les rapports entre Le Liquide c\u00e9phalo-rachidien et La circulation sanguine. Archives Internationales De Physiologie. 1921;17:138\u201392.","journal-title":"Archives Internationales De Physiologie"},{"key":"7288_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0012-1606(81)90382-1","volume":"84","author":"PA Stewart","year":"1981","unstructured":"Stewart PA, Wiley MJ. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail\u2013chick transplantation chimeras. Dev Biol. 1981;84:183\u201392.","journal-title":"Dev Biol"},{"key":"7288_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/1742-2094-9-273","volume":"9","author":"R Harati","year":"2012","unstructured":"Harati R, Villegier AS, Banks WA, Mabondzo A. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. J Neuroinflammation. 2012;9:273.","journal-title":"J Neuroinflammation"},{"key":"7288_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-180098","volume":"63","author":"Z Cai","year":"2018","unstructured":"Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q. Role of Blood-Brain barrier in alzheimer\u2019s disease. J Alzheimers Dis. 2018;63:1223\u201334.","journal-title":"J Alzheimers Dis"},{"key":"7288_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrclinonc.2011.58","volume":"8","author":"AF Eichler","year":"2011","unstructured":"Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK. The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol. 2011;8:344\u201356.","journal-title":"Nat Rev Clin Oncol"},{"key":"7288_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Praca C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34\u201347.","journal-title":"J Control Release"},{"key":"7288_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","volume":"44","author":"M Segarra","year":"2021","unstructured":"Segarra M, Aburto MR, Acker-Palmer A. Blood-Brain barrier dynamics to maintain brain homeostasis. Trends Neurosci. 2021;44:393\u2013405.","journal-title":"Trends Neurosci"},{"key":"7288_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00232-015-9778-9","volume":"248","author":"CW Fong","year":"2015","unstructured":"Fong CW. Permeability of the Blood-Brain barrier: molecular mechanism of transport of drugs and physiologically important compounds. J Membr Biol. 2015;248:651\u201369.","journal-title":"J Membr Biol"},{"key":"7288_CR23","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I. The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18:2489\u2013501.","journal-title":"Cell Mol Immunol"},{"key":"7288_CR24","doi-asserted-by":"crossref","unstructured":"Murphy K, Weaver C. Janeway\u2019s immunobiology. Garland science. 2016.","DOI":"10.1201\/9781315533247"},{"key":"7288_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3389\/fimmu.2018.00678","volume":"9","author":"ME Schmidt","year":"2018","unstructured":"Schmidt ME, Varga SM. The CD8 T cell response to respiratory virus infections. Front Immunol. 2018;9:678.","journal-title":"Front Immunol"},{"key":"7288_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","volume":"8","author":"A Takeuchi","year":"2017","unstructured":"Takeuchi A, Saito T. CD4 CTL, a cytotoxic subset of CD4(+) T Cells, their differentiation and function. Front Immunol. 2017;8:194.","journal-title":"Front Immunol"},{"key":"7288_CR27","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1158\/1078-0432.CCR-16-0249","volume":"22","author":"A Martens","year":"2016","unstructured":"Martens A, Wistuba-Hamprecht K, Yuan J, Postow MA, Wong P, Capone M, Madonna G, Khammari A, Schilling B, Sucker A, et al. Increases in absolute lymphocytes and Circulating CD4\u2009+\u2009and CD8\u2009+\u2009T cells are associated with positive clinical outcome of melanoma patients treated with ipilimumab. Clin Cancer Res. 2016;22:4848\u201358.","journal-title":"Clin Cancer Res"},{"key":"7288_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20091918","volume":"207","author":"SA Quezada","year":"2010","unstructured":"Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med. 2010;207:637\u201350.","journal-title":"J Exp Med"},{"key":"7288_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/cmi.2015.23","volume":"12","author":"X Zhou","year":"2015","unstructured":"Zhou X, Tang J, Cao H, Fan H, Li B. Tissue resident regulatory T cells: novel therapeutic targets for human disease. Cell Mol Immunol. 2015;12:543\u201352.","journal-title":"Cell Mol Immunol"},{"key":"7288_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","volume":"39","author":"P Georgiev","year":"2019","unstructured":"Georgiev P, Charbonnier LM, Chatila TA. Regulatory T cells: the many faces of Foxp3. J Clin Immunol. 2019;39:623\u201340.","journal-title":"J Clin Immunol"},{"key":"7288_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"7288_CR32","doi-asserted-by":"publisher","first-page":"eadm8859","DOI":"10.1126\/scitranslmed.adm8859","volume":"16","author":"P Ho","year":"2024","unstructured":"Ho P, Cahir-McFarland E, Fontenot JD, Lodie T, Nada A, Tang Q, Turka LA, Bluestone JA. Harnessing regulatory T cells to Establish immune tolerance. Sci Transl Med. 2024;16:eadm8859.","journal-title":"Sci Transl Med"},{"key":"7288_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16:356\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"7288_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445\u201389.","journal-title":"Annu Rev Immunol"},{"key":"7288_CR35","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2018.01364","volume":"9","author":"T Komai","year":"2018","unstructured":"Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, Shoda H, Yamamoto K, Fujio K. Transforming growth Factor-beta and Interleukin-10 synergistically regulate humoral immunity via modulating metabolic signals. Front Immunol. 2018;9:1364.","journal-title":"Front Immunol"},{"key":"7288_CR36","doi-asserted-by":"crossref","unstructured":"McGinley AM, Edwards SC, Raverdeau M, Mills KHG. Th17 cells, gammadelta T cells and their interplay in EAE and multiple sclerosis. J Autoimmun. 2018.","DOI":"10.1016\/j.jaut.2018.01.001"},{"key":"7288_CR37","doi-asserted-by":"publisher","first-page":"e0135898","DOI":"10.1371\/journal.pone.0135898","volume":"10","author":"K Derkow","year":"2015","unstructured":"Derkow K, Kruger C, Dembny P, Lehnardt S. Microglia induce neurotoxic IL-17\u2009+\u2009gammadelta T cells dependent on TLR2, TLR4, and TLR9 activation. PLoS ONE. 2015;10:e0135898.","journal-title":"PLoS ONE"},{"key":"7288_CR38","doi-asserted-by":"publisher","first-page":"2153534","DOI":"10.1080\/21645515.2022.2153534","volume":"18","author":"J Verreycken","year":"2022","unstructured":"Verreycken J, Baeten P, Broux B. Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers. Hum Vaccin Immunother. 2022;18:2153534.","journal-title":"Hum Vaccin Immunother"},{"key":"7288_CR39","doi-asserted-by":"publisher","first-page":"e0251601","DOI":"10.1371\/journal.pone.0251601","volume":"16","author":"HW Caplan","year":"2021","unstructured":"Caplan HW, Prabhakara KS, Toledano Furman NE, Zorofchian S, Martin C, Xue H, Olson SD, Cox CS Jr. Human-derived Treg and MSC combination therapy May augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model. PLoS ONE. 2021;16:e0251601.","journal-title":"PLoS ONE"},{"key":"7288_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fimmu.2015.00441","volume":"6","author":"KN Brazin","year":"2015","unstructured":"Brazin KN, Mallis RJ, Das DK, Feng Y, Hwang W, Wang JH, Wagner G, Lang MJ, Reinherz EL. Structural features of the alphabetatcr mechanotransduction apparatus that promote pMHC discrimination. Front Immunol. 2015;6:441.","journal-title":"Front Immunol"},{"key":"7288_CR41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1158\/2326-6066.CIR-14-0161","volume":"2","author":"ML Dustin","year":"2014","unstructured":"Dustin ML. The immunological synapse. Cancer Immunol Res. 2014;2:1023\u201333.","journal-title":"Cancer Immunol Res"},{"key":"7288_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4049\/jimmunol.1400322","volume":"193","author":"ML Bettini","year":"2014","unstructured":"Bettini ML, Guy C, Dash P, Vignali KM, Hamm DE, Dobbins J, Gagnon E, Thomas PG, Wucherpfennig KW, Vignali DA. Membrane association of the CD3epsilon signaling domain is required for optimal T cell development and function. J Immunol. 2014;193:258\u201367.","journal-title":"J Immunol"},{"key":"7288_CR43","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3389\/fimmu.2017.01467","volume":"8","author":"S Zumerle","year":"2017","unstructured":"Zumerle S, Molon B, Viola A. Membrane rafts in T cell activation: A spotlight on CD28 costimulation. Front Immunol. 2017;8:1467.","journal-title":"Front Immunol"},{"key":"7288_CR44","doi-asserted-by":"publisher","first-page":"e0200725","DOI":"10.1371\/journal.pone.0200725","volume":"13","author":"K Faia","year":"2018","unstructured":"Faia K, White K, Murphy E, Proctor J, Pink M, Kosmider N, McGovern K, Kutok J. The phosphoinositide-3 kinase (PI3K)-delta,gamma inhibitor, Duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies. PLoS ONE. 2018;13:e0200725.","journal-title":"PLoS ONE"},{"key":"7288_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, Gogenur I. Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124:359\u201367.","journal-title":"Br J Cancer"},{"key":"7288_CR46","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.molcel.2016.01.009","volume":"61","author":"Q Fu","year":"2016","unstructured":"Fu Q, Fu TM, Cruz AC, Sengupta P, Thomas SK, Wang S, Siegel RM, Wu H, Chou JJ. Structural basis and functional role of intramembrane trimerization of the Fas\/CD95 death receptor. Mol Cell. 2016;61:602\u201313.","journal-title":"Mol Cell"},{"key":"7288_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cell.2016.01.021","volume":"165","author":"R Basu","year":"2016","unstructured":"Basu R, Whitlock BM, Husson J, Le Floc\u2019h A, Jin W, Oyler-Yaniv A, Dotiwala F, Giannone G, Hivroz C, Biais N, et al. Cytotoxic T cells use mechanical force to potentiate target cell killing. Cell. 2016;165:100\u201310.","journal-title":"Cell"},{"key":"7288_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/cmi.2011.45","volume":"9","author":"C Gordy","year":"2012","unstructured":"Gordy C, He YW. Endocytosis by target cells: an essential means for perforin- and granzyme-mediated killing. Cell Mol Immunol. 2012;9:5\u20136.","journal-title":"Cell Mol Immunol"},{"key":"7288_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000325265","volume":"3","author":"YT Bryceson","year":"2011","unstructured":"Bryceson YT, Chiang SC, Darmanin S, Fauriat C, Schlums H, Theorell J, Wood SM. Molecular mechanisms of natural killer cell activation. J Innate Immun. 2011;3:216\u201326.","journal-title":"J Innate Immun"},{"key":"7288_CR50","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1073\/pnas.1913220117","volume":"117","author":"F Tamzalit","year":"2020","unstructured":"Tamzalit F, Tran D, Jin W, Boyko V, Bazzi H, Kepecs A, Kam LC, Anderson KV, Huse M. Centrioles control the capacity, but not the specificity, of cytotoxic T cell killing. Proc Natl Acad Sci U S A. 2020;117:4310\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7288_CR51","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1083\/jcb.200604015","volume":"174","author":"RM Luik","year":"2006","unstructured":"Luik RM, Wu MM, Buchanan J, Lewis RS. The elementary unit of store-operated Ca2\u2009+\u2009entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J Cell Biol. 2006;174:815\u201325.","journal-title":"J Cell Biol"},{"key":"7288_CR52","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1073\/pnas.0706122105","volume":"105","author":"MI Lioudyno","year":"2008","unstructured":"Lioudyno MI, Kozak JA, Penna A, Safrina O, Zhang SL, Sen D, Roos J, Stauderman KA, Cahalan MD. Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. Proc Natl Acad Sci U S A. 2008;105:2011\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7288_CR53","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.it.2020.06.012","volume":"41","author":"M Vaeth","year":"2020","unstructured":"Vaeth M, Kahlfuss S, Feske S. CRAC channels and calcium signaling in T Cell-Mediated immunity. Trends Immunol. 2020;41:878\u2013901.","journal-title":"Trends Immunol"},{"key":"7288_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ceca.2008.07.003","volume":"45","author":"A Quintana","year":"2009","unstructured":"Quintana A, Kummerow C, Junker C, Becherer U, Hoth M. Morphological changes of T cells following formation of the immunological synapse modulate intracellular calcium signals. Cell Calcium. 2009;45:109\u201322.","journal-title":"Cell Calcium"},{"key":"7288_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4049\/jimmunol.0902872","volume":"184","author":"C Schwindling","year":"2010","unstructured":"Schwindling C, Quintana A, Krause E, Hoth M. Mitochondria positioning controls local calcium influx in T cells. J Immunol. 2010;184:184\u201390.","journal-title":"J Immunol"},{"key":"7288_CR56","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/emboj.2011.289","volume":"30","author":"A Quintana","year":"2011","unstructured":"Quintana A, Pasche M, Junker C, Al-Ansary D, Rieger H, Kummerow C, Nunez L, Villalobos C, Meraner P, Becherer U, et al. Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. EMBO J. 2011;30:3895\u2013912.","journal-title":"EMBO J"},{"key":"7288_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/imr.12123","volume":"256","author":"A Babich","year":"2013","unstructured":"Babich A, Burkhardt JK. Coordinate control of cytoskeletal remodeling and calcium mobilization during T-cell activation. Immunol Rev. 2013;256:80\u201394.","journal-title":"Immunol Rev"},{"key":"7288_CR58","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/eji.201344011","volume":"44","author":"M Halimani","year":"2014","unstructured":"Halimani M, Pattu V, Marshall MR, Chang HF, Matti U, Jung M, Becherer U, Krause E, Hoth M, Schwarz EC, Rettig J. Syntaxin11 serves as a t-SNARE for the fusion of lytic granules in human cytotoxic T lymphocytes. Eur J Immunol. 2014;44:573\u201384.","journal-title":"Eur J Immunol"},{"key":"7288_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1083\/jcb.201411093","volume":"210","author":"MR Marshall","year":"2015","unstructured":"Marshall MR, Pattu V, Halimani M, Maier-Peuschel M, Muller ML, Becherer U, Hong W, Hoth M, Tschernig T, Bryceson YT, Rettig J. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135\u201351.","journal-title":"J Cell Biol"},{"key":"7288_CR60","doi-asserted-by":"publisher","first-page":"1177670","DOI":"10.3389\/fimmu.2023.1177670","volume":"14","author":"HF Chang","year":"2023","unstructured":"Chang HF, Schirra C, Pattu V, Krause E, Becherer U. Lytic granule exocytosis at immune synapses: lessons from neuronal synapses. Front Immunol. 2023;14:1177670.","journal-title":"Front Immunol"},{"key":"7288_CR61","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0002-9440(10)63481-5","volume":"163","author":"K Dornmair","year":"2003","unstructured":"Dornmair K, Goebels N, Weltzien HU, Wekerle H, Hohlfeld R. T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors. Am J Pathol. 2003;163:1215\u201326.","journal-title":"Am J Pathol"},{"key":"7288_CR62","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3389\/fimmu.2018.01816","volume":"9","author":"I Shevchenko","year":"2018","unstructured":"Shevchenko I, Bazhin AV. Metabolic checkpoints: novel avenues for immunotherapy of cancer. Front Immunol. 2018;9:1816.","journal-title":"Front Immunol"},{"key":"7288_CR63","first-page":"127","volume":"410","author":"N Joller","year":"2017","unstructured":"Joller N, Kuchroo VK. Tim-3, Lag-3, and TIGIT. Curr Top Microbiol Immunol. 2017;410:127\u201356.","journal-title":"Curr Top Microbiol Immunol"},{"key":"7288_CR64","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/14728222.2018.1444753","volume":"22","author":"F Amatore","year":"2018","unstructured":"Amatore F, Gorvel L, Olive D. Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy. Expert Opin Ther Targets. 2018;22:343\u201351.","journal-title":"Expert Opin Ther Targets"},{"key":"7288_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coi.2017.01.005","volume":"45","author":"D Bethmann","year":"2017","unstructured":"Bethmann D, Feng Z, Fox BA. Immunoprofiling as a predictor of patient\u2019s response to cancer therapy-promises and challenges. Curr Opin Immunol. 2017;45:60\u201372.","journal-title":"Curr Opin Immunol"},{"key":"7288_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel JJ, Chowell D, Chan TA. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer. 2019;19:133\u201350.","journal-title":"Nat Rev Cancer"},{"key":"7288_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00281-018-0714-9","volume":"41","author":"EV Schmidt","year":"2019","unstructured":"Schmidt EV. Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer. Semin Immunopathol. 2019;41:21\u201330.","journal-title":"Semin Immunopathol"},{"key":"7288_CR68","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.it.2018.12.003","volume":"40","author":"F Souza-Fonseca-Guimaraes","year":"2019","unstructured":"Souza-Fonseca-Guimaraes F, Cursons J, Huntington ND. The emergence of natural killer cells as a major target in cancer immunotherapy. Trends Immunol. 2019;40:142\u201358.","journal-title":"Trends Immunol"},{"key":"7288_CR69","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1816047","volume":"380","author":"RJ Motzer","year":"2019","unstructured":"Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, et al. Avelumab plus axitinib versus Sunitinib for advanced Renal-Cell carcinoma. N Engl J Med. 2019;380:1103\u201315.","journal-title":"N Engl J Med"},{"key":"7288_CR70","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, Van Cutsem E, McDermott R, Hill A, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch Repair-Deficient\/Microsatellite Instability-High metastatic colorectal cancer. J Clin Oncol. 2018;36:773\u20139.","journal-title":"J Clin Oncol"},{"key":"7288_CR71","doi-asserted-by":"publisher","first-page":"8568","DOI":"10.4049\/jimmunol.181.12.8568","volume":"181","author":"JD Brien","year":"2008","unstructured":"Brien JD, Uhrlaub JL, Nikolich-Zugich J. West nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol. 2008;181:8568\u201375.","journal-title":"J Immunol"},{"key":"7288_CR72","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2008.01.013","volume":"132","author":"JH Yeh","year":"2008","unstructured":"Yeh JH, Sidhu SS, Chan AC. Regulation of a late phase of T cell Polarity and effector functions by Crtam. Cell. 2008;132:846\u201359.","journal-title":"Cell"},{"key":"7288_CR73","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.4049\/jimmunol.2300748","volume":"212","author":"DM Jones","year":"2024","unstructured":"Jones DM, Tuazon JA, Read KA, Leonard MR, Pokhrel S, Sreekumar BK, Warren RT, Yount JS, Collins PL, Oestreich KJ. Cytotoxic programming of CD4\u2009+\u2009T cells is regulated by opposing actions of the related transcription factors Eos and Aiolos. J Immunol. 2024;212:1129\u201341.","journal-title":"J Immunol"},{"key":"7288_CR74","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.celrep.2016.10.013","volume":"17","author":"T Donnarumma","year":"2016","unstructured":"Donnarumma T, Young GR, Merkenschlager J, Eksmond U, Bongard N, Nutt SL, Boyer C, Dittmer U, Le-Trilling VT, Trilling M, et al. Opposing development of cytotoxic and follicular helper CD4 T cells controlled by the TCF-1-Bcl6 nexus. Cell Rep. 2016;17:1571\u201383.","journal-title":"Cell Rep"},{"key":"7288_CR75","doi-asserted-by":"crossref","unstructured":"Roselli E, Boucher JC, Li G, Kotani H, Spitler K, Reid K, Cervantes EV, Bulliard Y, Tu N, Lee SB, et al. 4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2021-003354"},{"key":"7288_CR76","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.4049\/jimmunol.1003304","volume":"186","author":"DL Barber","year":"2011","unstructured":"Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated Inhibition. J Immunol. 2011;186:1598\u2013607.","journal-title":"J Immunol"},{"key":"7288_CR77","doi-asserted-by":"publisher","first-page":"e1005490","DOI":"10.1371\/journal.ppat.1005490","volume":"12","author":"P Jayaraman","year":"2016","unstructured":"Jayaraman P, Jacques MK, Zhu C, Steblenko KM, Stowell BL, Madi A, Anderson AC, Kuchroo VK, Behar SM. TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection. PLoS Pathog. 2016;12:e1005490.","journal-title":"PLoS Pathog"},{"key":"7288_CR78","doi-asserted-by":"publisher","first-page":"1271236","DOI":"10.3389\/fimmu.2023.1271236","volume":"14","author":"A Malyshkina","year":"2023","unstructured":"Malyshkina A, Bruggemann A, Paschen A, Dittmer U. Cytotoxic CD4(+) T cells in chronic viral infections and cancer. Front Immunol. 2023;14:1271236.","journal-title":"Front Immunol"},{"key":"7288_CR79","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ni.1887","volume":"11","author":"AC Carpenter","year":"2010","unstructured":"Carpenter AC, Bosselut R. Decision checkpoints in the thymus. Nat Immunol. 2010;11:666\u201373.","journal-title":"Nat Immunol"},{"key":"7288_CR80","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.145.5.1387","volume":"145","author":"P Billings","year":"1977","unstructured":"Billings P, Burakoff S, Dorf ME, Benacerraf B. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products. J Exp Med. 1977;145:1387\u201392.","journal-title":"J Exp Med"},{"key":"7288_CR81","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1073\/pnas.79.7.2365","volume":"79","author":"AM Krensky","year":"1982","unstructured":"Krensky AM, Reiss CS, Mier JW, Strominger JL, Burakoff SJ. Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A. 1982;79:2365\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7288_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ni.2518","volume":"14","author":"BS Reis","year":"2013","unstructured":"Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I, Mucida D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity. Nat Immunol. 2013;14:271\u201380.","journal-title":"Nat Immunol"},{"key":"7288_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20150519","volume":"213","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi A, Badr Mel S, Miyauchi K, Ishihara C, Onishi R, Guo Z, Sasaki Y, Ike H, Takumi A, Tsuji NM, et al. CRTAM determines the CD4\u2009+\u2009cytotoxic T lymphocyte lineage. J Exp Med. 2016;213:123\u201338.","journal-title":"J Exp Med"},{"key":"7288_CR84","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ. Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol. 2002;2:735\u201347.","journal-title":"Nat Rev Immunol"},{"key":"7288_CR85","doi-asserted-by":"publisher","first-page":"e60420","DOI":"10.1371\/journal.pone.0060420","volume":"8","author":"SK Hildemann","year":"2013","unstructured":"Hildemann SK, Eberlein J, Davenport B, Nguyen TT, Victorino F, Homann D. High efficiency of antiviral CD4(+) killer T cells. PLoS ONE. 2013;8:e60420.","journal-title":"PLoS ONE"},{"key":"7288_CR86","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","volume":"168","author":"V Appay","year":"2002","unstructured":"Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol. 2002;168:5954\u20138.","journal-title":"J Immunol"},{"key":"7288_CR87","doi-asserted-by":"crossref","unstructured":"Preglej T, Hamminger P, Luu M, Bulat T, Andersen L, Goschl L, Stolz V, Rica R, Sandner L, Waltenberger D, et al. Histone deacetylases 1 and 2 restrain CD4\u2009+\u2009cytotoxic T lymphocyte differentiation. JCI Insight. 2020;5.","DOI":"10.1172\/jci.insight.133393"},{"key":"7288_CR88","doi-asserted-by":"crossref","unstructured":"Patil VS, Madrigal A, Schmiedel BJ, Clarke J, O\u2019Rourke P, de Silva AD, Harris E, Peters B, Seumois G, Weiskopf D, et al. Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis. Sci Immunol. 2018;3.","DOI":"10.1126\/sciimmunol.aan8664"},{"key":"7288_CR89","doi-asserted-by":"publisher","first-page":"e0056621","DOI":"10.1128\/JVI.00566-21","volume":"95","author":"CJ Knudson","year":"2021","unstructured":"Knudson CJ, Ferez M, Alves-Peixoto P, Erkes DA, Melo-Silva CR, Tang L, Snyder CM, Sigal LJ. Mechanisms of antiviral cytotoxic CD4 T cell differentiation. J Virol. 2021;95:e0056621.","journal-title":"J Virol"},{"key":"7288_CR90","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.1073\/pnas.1202143109","volume":"109","author":"M Fang","year":"2012","unstructured":"Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, Ma X, Shamsedeen AR, Eisenlohr LC, Sigal LJ. Perforin-dependent CD4\u2009+\u2009T-cell cytotoxicity contributes to control a murine poxvirus infection. Proc Natl Acad Sci U S A. 2012;109:9983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7288_CR91","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","volume":"27","author":"AM Miggelbrink","year":"2021","unstructured":"Miggelbrink AM, Jackson JD, Lorrey SJ, Srinivasan ES, Waibl-Polania J, Wilkinson DS, Fecci PE. CD4 T-Cell exhaustion: does it exist and what are its roles in cancer? Clin Cancer Res. 2021;27:5742\u201352.","journal-title":"Clin Cancer Res"},{"key":"7288_CR92","doi-asserted-by":"publisher","first-page":"167219","DOI":"10.1016\/j.bbadis.2024.167219","volume":"1870","author":"J Flores-Gonzalez","year":"2024","unstructured":"Flores-Gonzalez J, Ramon-Luing LA, Falfan-Valencia R, Batista CVF, Soto-Alvarez S, Huerta-Nunez L, Chavez-Galan L. The presence of cytotoxic CD4 and exhausted-like CD8\u2009+\u2009T-cells is a signature of active tuberculosis. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167219.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7288_CR93","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-5728(83)90025-5","volume":"5","author":"PR Wyde","year":"1983","unstructured":"Wyde PR, Gilbert BE, Levy BM. Evidence that T-lymphocytes are part of the blood-brain barrier to virus dissemination. J Neuroimmunol. 1983;5:47\u201358.","journal-title":"J Neuroimmunol"},{"key":"7288_CR94","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-065X.1987.tb00537.x","volume":"100","author":"DA Hafler","year":"1987","unstructured":"Hafler DA, Weiner HL. T cells in multiple sclerosis and inflammatory central nervous system diseases. Immunol Rev. 1987;100:307\u201332.","journal-title":"Immunol Rev"},{"key":"7288_CR95","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ana.410220121","volume":"22","author":"DA Hafler","year":"1987","unstructured":"Hafler DA, Weiner HL. In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis. Ann Neurol. 1987;22:89\u201393.","journal-title":"Ann Neurol"},{"key":"7288_CR96","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.4049\/jimmunol.159.5.2399","volume":"159","author":"LB Gordon","year":"1997","unstructured":"Gordon LB, Nolan SC, Cserr HF, Knopf PM, Harling-Berg CJ. Growth of P511 mastocytoma cells in BALB\/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity. J Immunol. 1997;159:2399\u2013408.","journal-title":"J Immunol"},{"key":"7288_CR97","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12967-015-0451-y","volume":"13","author":"PY Chen","year":"2015","unstructured":"Chen PY, Hsieh HY, Huang CY, Lin CY, Wei KC, Liu HL. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study. J Transl Med. 2015;13:93.","journal-title":"J Transl Med"},{"key":"7288_CR98","doi-asserted-by":"crossref","unstructured":"Angelova AL, Barf M, Geletneky K, Unterberg A, Rommelaere J. Immunotherapeutic potential of oncolytic H-1 parvovirus: hints of glioblastoma microenvironment conversion towards immunogenicity. Viruses. 2017;9.","DOI":"10.3390\/v9120382"},{"key":"7288_CR99","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.ymthe.2017.08.016","volume":"25","author":"K Geletneky","year":"2017","unstructured":"Geletneky K, Hajda J, Angelova AL, Leuchs B, Capper D, Bartsch AJ, Neumann JO, Schoning T, Husing J, Beelte B, et al. Oncolytic H-1 parvovirus shows safety and signs of Immunogenic activity in a first phase I\/IIa glioblastoma trial. Mol Ther. 2017;25:2620\u201334.","journal-title":"Mol Ther"},{"key":"7288_CR100","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1021\/acsnano.3c13088","volume":"18","author":"Y Peng","year":"2024","unstructured":"Peng Y, Zhan M, Karpus A, Zou Y, Mignani S, Majoral JP, Shi X, Shen M. Brain delivery of biomimetic phosphorus Dendrimer\/Antibody nanocomplexes for enhanced glioma immunotherapy via immune modulation of T cells and natural killer cells. ACS Nano. 2024;18:10142\u201355.","journal-title":"ACS Nano"},{"key":"7288_CR101","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jconrel.2022.10.037","volume":"352","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang M, Zhang Q, Mohammadniaei M, Shen J, Sun Y. Brain-targeted antigen-generating nanoparticles improve glioblastoma prognosis. J Control Release. 2022;352:399\u2013410.","journal-title":"J Control Release"},{"key":"7288_CR102","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jconrel.2022.04.048","volume":"347","author":"J Wei","year":"2022","unstructured":"Wei J, Wu D, Shao Y, Guo B, Jiang J, Chen J, Zhang J, Meng F, Zhong Z. ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy. J Control Release. 2022;347:68\u201377.","journal-title":"J Control Release"},{"key":"7288_CR103","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ymthe.2018.10.007","volume":"27","author":"F Pohl-Guimaraes","year":"2019","unstructured":"Pohl-Guimaraes F, Yang C, Dyson KA, Wildes TJ, Drake J, Huang J, Flores C, Sayour EJ, Mitchell DA. RNA-Modified T cells mediate effective delivery of Immunomodulatory cytokines to brain tumors. Mol Ther. 2019;27:837\u201349.","journal-title":"Mol Ther"},{"key":"7288_CR104","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.1038\/s41598-018-30072-x","volume":"8","author":"X Wang","year":"2018","unstructured":"Wang X, Xiong Z, Liu Z, Huang X, Jiang X. Angiopep-2\/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma. Sci Rep. 2018;8:12827.","journal-title":"Sci Rep"},{"key":"7288_CR105","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0022-510X(93)90166-V","volume":"117","author":"N Tsukada","year":"1993","unstructured":"Tsukada N, Matsuda M, Miyagi K, Yanagisawa N. Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis. J Neurol Sci. 1993;117:140\u20137.","journal-title":"J Neurol Sci"},{"key":"7288_CR106","doi-asserted-by":"publisher","first-page":"e3037","DOI":"10.1371\/journal.pone.0003037","volume":"3","author":"GL Suidan","year":"2008","unstructured":"Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS ONE. 2008;3:e3037.","journal-title":"PLoS ONE"},{"key":"7288_CR107","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4049\/jimmunol.0902773","volume":"184","author":"GL Suidan","year":"2010","unstructured":"Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, Pirko I, Seroogy KB, Johnson AJ. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol. 2010;184:1031\u201340.","journal-title":"J Immunol"},{"key":"7288_CR108","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1742-2094-9-218","volume":"9","author":"GL Suidan","year":"2012","unstructured":"Suidan GL, Dickerson JW, Johnson HL, Chan TW, Pavelko KD, Pirko I, Seroogy KB, Johnson AJ. Preserved vascular integrity and enhanced survival following neuropilin-1 Inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability. J Neuroinflammation. 2012;9:218.","journal-title":"J Neuroinflammation"},{"key":"7288_CR109","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.4049\/jimmunol.1100885","volume":"187","author":"R Schneider","year":"2011","unstructured":"Schneider R, Mohebiany AN, Ifergan I, Beauseigle D, Duquette P, Prat A, Arbour N. B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients. J Immunol. 2011;187:4119\u201328.","journal-title":"J Immunol"},{"key":"7288_CR110","doi-asserted-by":"publisher","first-page":"103078","DOI":"10.1016\/j.msard.2021.103078","volume":"53","author":"AA Elkhodiry","year":"2021","unstructured":"Elkhodiry AA, Zamzam DA, El Tayebi HM. miR-155 and functional proteins of CD8\u2009+\u2009T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2021;53:103078.","journal-title":"Mult Scler Relat Disord"},{"key":"7288_CR111","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-014-1244-8","volume":"127","author":"G Kooij","year":"2014","unstructured":"Kooij G, Kroon J, Paul D, Reijerkerk A, Geerts D, van der Pol SM, van Het Hof B, Drexhage JA, van Vliet SJ, Hekking LH, et al. P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma. Acta Neuropathol. 2014;127:699\u2013711.","journal-title":"Acta Neuropathol"},{"key":"7288_CR112","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781\u201390.","journal-title":"Nat Rev Immunol"},{"key":"7288_CR113","doi-asserted-by":"publisher","first-page":"e81455","DOI":"10.1371\/journal.pone.0081455","volume":"8","author":"T Ruck","year":"2013","unstructured":"Ruck T, Bittner S, Gross CC, Breuer J, Albrecht S, Korr S, Gobel K, Pankratz S, Henschel CM, Schwab N, et al. CD4\u2009+\u2009NKG2D\u2009+\u2009T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation. PLoS ONE. 2013;8:e81455.","journal-title":"PLoS ONE"},{"key":"7288_CR114","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"key":"7288_CR115","doi-asserted-by":"publisher","first-page":"106801","DOI":"10.1016\/j.compbiomed.2023.106801","volume":"158","author":"S Yan","year":"2023","unstructured":"Yan S, Si Y, Zhou W, Cheng R, Wang P, Wang D, Ding W, Shi W, Jiang Q, Yang F, Yao L. Single-cell transcriptomics reveals the interaction between peripheral CD4(+) CTLs and mesencephalic endothelial cells mediated by IFNG in parkinson\u2019s disease. Comput Biol Med. 2023;158:106801.","journal-title":"Comput Biol Med"},{"key":"7288_CR116","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/j.1528-1167.2011.03080.x","volume":"52","author":"N Marchi","year":"2011","unstructured":"Marchi N, Johnson AJ, Puvenna V, Johnson HL, Tierney W, Ghosh C, Cucullo L, Fabene PF, Janigro D. Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia. 2011;52:1627\u201334.","journal-title":"Epilepsia"},{"key":"7288_CR117","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13365-013-0187-5","volume":"20","author":"HL Johnson","year":"2014","unstructured":"Johnson HL, Jin F, Pirko I, Johnson AJ. Theiler\u2019s murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption. J Neurovirol. 2014;20:107\u201312.","journal-title":"J Neurovirol"},{"key":"7288_CR118","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.24976\/Discov.Med.202335179.100","volume":"35","author":"P Xie","year":"2023","unstructured":"Xie P, Zhu S, Zhou H, Fang R, Zhuang J, Wen J, Yang M, He J. Rapamycin plays an Anti-Epileptic role by restoring Blood-Brain barrier Dysfunction, balancing T cell subsets and inhibiting neuronal apoptosis. Discov Med. 2023;35:1043\u201351.","journal-title":"Discov Med"},{"key":"7288_CR119","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/0271678X231214838","volume":"44","author":"S Zhou","year":"2024","unstructured":"Zhou S, Liu C, Wang J, Ye J, Lian Q, Gan L, Deng S, Xu T, Guo Y, Li W, et al. CCL5 mediated astrocyte-T cell interaction disrupts blood-brain barrier in mice after hemorrhagic stroke. J Cereb Blood Flow Metab. 2024;44:367\u201383.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7288_CR120","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jnnp-2014-308240","volume":"86","author":"TA Hardy","year":"2015","unstructured":"Hardy TA, O\u2019Brien B, Gerbis N, Barnett MH, Reddel SW, Brewer J, Herkes GK, Silberstein P, Garsia RJ, Watson JD, et al. Brain histopathology in three cases of susac\u2019s syndrome: implications for lesion pathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2015;86:582\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7288_CR121","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1309\/AJCPERI7LC4VNFYK","volume":"136","author":"CM Magro","year":"2011","unstructured":"Magro CM, Poe JC, Lubow M, Susac JO. Susac syndrome: an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol. 2011;136:903\u201312.","journal-title":"Am J Clin Pathol"},{"key":"7288_CR122","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jns.2007.01.036","volume":"257","author":"JO Susac","year":"2007","unstructured":"Susac JO, Egan RA, Rennebohm RM, Lubow M. Susac\u2019s syndrome: 1975\u20132005 microangiopathy\/autoimmune endotheliopathy. J Neurol Sci. 2007;257:270\u20132.","journal-title":"J Neurol Sci"},{"key":"7288_CR123","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1038\/s41467-019-13593-5","volume":"10","author":"CC Gross","year":"2019","unstructured":"Gross CC, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, Troscher AR, Schulte-Mecklenbeck A, Herich S, Schneider-Hohendorf T, et al. CD8(+) T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun. 2019;10:5779.","journal-title":"Nat Commun"},{"key":"7288_CR124","doi-asserted-by":"crossref","unstructured":"Gonzalez-Fierro C, Fonte C, Dufourd E, Cazaentre V, Aydin S, Engelhardt B, Caspi RR, Xu B, Martin-Blondel G, Spicer JA, et al. Effects of a Small-Molecule Perforin inhibitor in a mouse model of CD8 T Cell-Mediated neuroinflammation. Neurol Neuroimmunol Neuroinflamm. 2023;10.","DOI":"10.1212\/NXI.0000000000200117"},{"key":"7288_CR125","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1176\/ajp.156.4.634","volume":"156","author":"N Muller","year":"1999","unstructured":"Muller N, Riedel M, Hadjamu M, Schwarz MJ, Ackenheil M, Gruber R. Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiatry. 1999;156:634\u20136.","journal-title":"Am J Psychiatry"},{"key":"7288_CR126","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijpara.2005.12.005","volume":"36","author":"S Potter","year":"2006","unstructured":"Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, Hunt NH. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol. 2006;36:485\u201396.","journal-title":"Int J Parasitol"},{"key":"7288_CR127","doi-asserted-by":"crossref","unstructured":"Huggins MA, Johnson HL, Jin F, A NS, Hanson LM, LaFrance SJ, Butler NS, Harty JT, Johnson AJ. Perforin expression by CD8 T cells is sufficient to cause fatal brain edema during experimental cerebral malaria. Infect Immun. 2017;85.","DOI":"10.1128\/IAI.00985-16"},{"key":"7288_CR128","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/emmm.201202273","volume":"5","author":"SW Howland","year":"2013","unstructured":"Howland SW, Poh CM, Gun SY, Claser C, Malleret B, Shastri N, Ginhoux F, Grotenbreg GM, Renia L. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med. 2013;5:984\u201399.","journal-title":"EMBO Mol Med"},{"key":"7288_CR129","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/IAI.00929-13","volume":"82","author":"X Wei","year":"2014","unstructured":"Wei X, Li Y, Sun X, Zhu X, Feng Y, Liu J, Jiang Y, Shang H, Cui L, Cao Y. Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity. Infect Immun. 2014;82:165\u201373.","journal-title":"Infect Immun"},{"key":"7288_CR130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/imm.13137","volume":"159","author":"JM Kuehlwein","year":"2020","unstructured":"Kuehlwein JM, Borsche M, Korir PJ, Risch F, Mueller AK, Hubner MP, Hildner K, Hoerauf A, Dunay IR, Schumak B. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation. Immunology. 2020;159:193\u2013204.","journal-title":"Immunology"},{"key":"7288_CR131","doi-asserted-by":"publisher","first-page":"711876","DOI":"10.3389\/fimmu.2021.711876","volume":"12","author":"JF Scheunemann","year":"2021","unstructured":"Scheunemann JF, Reichwald JJ, Korir PJ, Kuehlwein JM, Jenster LM, Hammerschmidt-Kamper C, Lewis MD, Klocke K, Borsche M, Schwendt KE, et al. Eosinophils suppress the migration of T cells into the brain of plasmodium berghei-Infected Ifnar1(-\/-) mice and protect them from experimental cerebral malaria. Front Immunol. 2021;12:711876.","journal-title":"Front Immunol"},{"key":"7288_CR132","unstructured":"Sharma I, Kataria P, Das J. Cerebral malaria pathogenesis: dissecting the role of CD4(+) and CD8(+) T-cells as major effectors in disease pathology. Int Rev Immunol. 2024:1\u201318."},{"key":"7288_CR133","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood.V99.1.88","volume":"99","author":"Y Yamano","year":"2002","unstructured":"Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). Blood. 2002;99:88\u201394.","journal-title":"Blood"},{"key":"7288_CR134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1006\/cbir.1998.0241","volume":"22","author":"N Mor-Vaknin","year":"1998","unstructured":"Mor-Vaknin N, Turgeman H, Torgeman A, Wolfson M, Huleihel M, Aboud M. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis\/HTLV-I associated myelopathy. Cell Biol Int. 1998;22:95\u2013103.","journal-title":"Cell Biol Int"},{"key":"7288_CR135","doi-asserted-by":"crossref","unstructured":"Ma G, Yasunaga JI, Ohshima K, Matsumoto T, Matsuoka M. Pentosan polysulfate demonstrates Anti-human T-Cell leukemia virus type 1 activities in vitro and in vivo. J Virol. 2019;93.","DOI":"10.1128\/JVI.00413-19"},{"key":"7288_CR136","doi-asserted-by":"publisher","first-page":"27670","DOI":"10.1038\/srep27670","volume":"6","author":"TT Tsai","year":"2016","unstructured":"Tsai TT, Chen CL, Lin YS, Chang CP, Tsai CC, Cheng YL, Huang CC, Ho CJ, Lee YC, Lin LT, et al. Microglia retard dengue virus-induced acute viral encephalitis. Sci Rep. 2016;6:27670.","journal-title":"Sci Rep"},{"key":"7288_CR137","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00005072-197701000-00003","volume":"36","author":"DL Camenga","year":"1977","unstructured":"Camenga DL, Walker DH, Murphy FA. Anticonvulsant prolongation of survival in adult murine lymphocytic choriomeningitis. I. Drug treatment and virologic studies. J Neuropathol Exp Neurol. 1977;36:9\u201320.","journal-title":"J Neuropathol Exp Neurol"},{"key":"7288_CR138","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00685249","volume":"63","author":"O Marker","year":"1984","unstructured":"Marker O, Nielsen MH, Diemer NH. The permeability of the blood-brain barrier in mice suffering from fatal lymphocytic choriomeningitis virus infection. Acta Neuropathol. 1984;63:229\u201339.","journal-title":"Acta Neuropathol"},{"key":"7288_CR139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature07591","volume":"457","author":"JV Kim","year":"2009","unstructured":"Kim JV, Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature. 2009;457:191\u20135.","journal-title":"Nature"},{"key":"7288_CR140","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.omtm.2023.08.021","volume":"31","author":"Y Guo","year":"2023","unstructured":"Guo Y, Chen J, Ji W, Xu L, Xie Y, He S, Lai C, Hou K, Li Z, Chen G, Wu Z. High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain. Mol Ther Methods Clin Dev. 2023;31:101102.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"7288_CR141","unstructured":"Stewart-Hutchinson PJ. The pathogenic role of CD8\u2009+\u2009T cells in experimental cerebral malaria. New York University. 2014."},{"key":"7288_CR142","doi-asserted-by":"publisher","first-page":"1250123","DOI":"10.3389\/fnmol.2023.1250123","volume":"16","author":"AL Nair","year":"2023","unstructured":"Nair AL, Groenendijk L, Overdevest R, Fowke TM, Annida R, Mocellin O, de Vries HE, Wevers NR. Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions. Front Mol Neurosci. 2023;16:1250123.","journal-title":"Front Mol Neurosci"},{"key":"7288_CR143","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00018-019-03030-7","volume":"76","author":"P Berndt","year":"2019","unstructured":"Berndt P, Winkler L, Cording J, Breitkreuz-Korff O, Rex A, Dithmer S, Rausch V, Blasig R, Richter M, Sporbert A, et al. Tight junction proteins at the blood-brain barrier: Far more than claudin-5. Cell Mol Life Sci. 2019;76:1987\u20132002.","journal-title":"Cell Mol Life Sci"},{"key":"7288_CR144","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/bdd.2331","volume":"44","author":"B Cox","year":"2023","unstructured":"Cox B, Nicolai J, Williamson B. The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery. Biopharm Drug Dispos. 2023;44:113\u201326.","journal-title":"Biopharm Drug Dispos"},{"key":"7288_CR145","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985811429314","volume":"49","author":"RS Sellers","year":"2012","unstructured":"Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically Immunomodified mice. Vet Pathol. 2012;49:32\u201343.","journal-title":"Vet Pathol"},{"key":"7288_CR146","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2967\/jnumed.120.259325","volume":"63","author":"C Guglielmetti","year":"2022","unstructured":"Guglielmetti C, Levi J, Huynh TL, Tiret B, Blecha J, Tang R, VanBrocklin H, Chaumeil MM. Longitudinal imaging of T cells and inflammatory demyelination in a preclinical model of multiple sclerosis using (18)F-FAraG PET and MRI. J Nucl Med. 2022;63:140\u20136.","journal-title":"J Nucl Med"},{"key":"7288_CR147","doi-asserted-by":"publisher","first-page":"e2016","DOI":"10.1212\/WNL.0000000000010116","volume":"95","author":"T Coolen","year":"2020","unstructured":"Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, Creteur J, Henrard S, Goffard JC, Dewitte O, et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95:e2016\u201327.","journal-title":"Neurology"},{"key":"7288_CR148","doi-asserted-by":"publisher","first-page":"204173142210953","DOI":"10.1177\/20417314221095339","volume":"13","author":"F Fanizza","year":"2022","unstructured":"Fanizza F, Campanile M, Forloni G, Giordano C, Albani D. Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders. J Tissue Eng. 2022;13:20417314221095339.","journal-title":"J Tissue Eng"},{"key":"7288_CR149","doi-asserted-by":"publisher","first-page":"e1204507","DOI":"10.1080\/2162402X.2016.1204507","volume":"5","author":"H Inoue","year":"2016","unstructured":"Inoue H, Park JH, Kiyotani K, Zewde M, Miyashita A, Jinnin M, Kiniwa Y, Okuyama R, Tanaka R, Fujisawa Y, et al. Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma. Oncoimmunology. 2016;5:e1204507.","journal-title":"Oncoimmunology"},{"key":"7288_CR150","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1158\/2326-6066.CIR-23-0959","volume":"12","author":"SK Skadborg","year":"2024","unstructured":"Skadborg SK, Maarup S, Draghi A, Borch A, Hendriksen S, Mundt F, Pedersen V, Mann M, Christensen IJ, Skjoth-Ramussen J, et al. Nivolumab reaches brain lesions in patients with recurrent glioblastoma and induces T-cell activity and upregulation of checkpoint pathways. Cancer Immunol Res. 2024;12:1202\u201320.","journal-title":"Cancer Immunol Res"},{"key":"7288_CR151","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.4049\/jimmunol.176.7.4399","volume":"176","author":"L Liu","year":"2006","unstructured":"Liu L, Huang D, Matsui M, He TT, Hu T, Demartino J, Lu B, Gerard C, Ransohoff RM. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-\/- mice with experimental autoimmune encephalomyelitis. J Immunol. 2006;176:4399\u2013409.","journal-title":"J Immunol"},{"key":"7288_CR152","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1750-3639.2008.00154.x","volume":"18","author":"RE Kohler","year":"2008","unstructured":"Kohler RE, Comerford I, Townley S, Haylock-Jacobs S, Clark-Lewis I, McColl SR. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 2008;18:504\u201316.","journal-title":"Brain Pathol"},{"key":"7288_CR153","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12967-023-04044-3","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Xu Y, Guo P, Chen YJ, Zhou J, Xia M, Tan B, Liu X, Feng H, Chen Y. CCL5\/CCR5-mediated peripheral inflammation exacerbates blood\u2013brain barrier disruption after intracerebral hemorrhage in mice. J Transl Med. 2023;21:196.","journal-title":"J Transl Med"},{"key":"7288_CR154","doi-asserted-by":"publisher","first-page":"1169608","DOI":"10.3389\/fphar.2023.1169608","volume":"14","author":"Q Wu","year":"2023","unstructured":"Wu Q, Xia Y, Xiong X, Duan X, Pang X, Zhang F, Tang S, Su J, Wen S, Mei L, et al. Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint Blockade in solid tumors. Front Pharmacol. 2023;14:1169608.","journal-title":"Front Pharmacol"},{"key":"7288_CR155","doi-asserted-by":"publisher","first-page":"102115","DOI":"10.1016\/j.tranon.2024.102115","volume":"49","author":"H Shan","year":"2024","unstructured":"Shan H, Zheng G, Bao S, Yang H, Shrestha UD, Li G, Duan X, Du X, Ke T, Liao C. Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma. Transl Oncol. 2024;49:102115.","journal-title":"Transl Oncol"},{"key":"7288_CR156","doi-asserted-by":"crossref","unstructured":"Habib S, Singh M. Angiopep-2-Modified nanoparticles for Brain-Directed delivery of therapeutics: A review. Polym (Basel). 2022;14.","DOI":"10.3390\/polym14040712"},{"key":"7288_CR157","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-2094-10-12","volume":"10","author":"AS Prabowo","year":"2013","unstructured":"Prabowo AS, Iyer AM, Anink JJ, Spliet WG, van Rijen PC, Aronica E. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions. J Neuroinflammation. 2013;10:12.","journal-title":"J Neuroinflammation"},{"key":"7288_CR158","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s11682-024-00877-8","volume":"18","author":"A Gupta","year":"2024","unstructured":"Gupta A, Comfort B, Young K, Montgomery R. A pilot study to assess blood-brain barrier permeability in long COVID. Brain Imaging Behav. 2024;18:830\u20134.","journal-title":"Brain Imaging Behav"},{"key":"7288_CR159","doi-asserted-by":"crossref","unstructured":"Fujimoto T, Erickson MA, Banks WA. Neurotropism and blood-brain barrier involvement in COVID-19. Front. Drug Deliv. 2022;2:1073815.","DOI":"10.3389\/fddev.2022.1073815"},{"key":"7288_CR160","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/brain\/awae031","volume":"147","author":"TN Trevino","year":"2024","unstructured":"Trevino TN, Fogel AB, Otkiran G, Niladhuri SB, Sanborn MA, Class J, Almousawi AA, Vanhollebeke B, Tai LM, Rehman J, et al. Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse model. Brain. 2024;147:1636\u201343.","journal-title":"Brain"},{"key":"7288_CR161","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene C, Connolly R, Brennan D, Laffan A, O\u2019Keeffe E, Zaporojan L, O\u2019Callaghan J, Thomson B, Connolly E, Argue R, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421\u201332.","journal-title":"Nat Neurosci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07288-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:37:32Z","timestamp":1781624252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":161,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7288"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07288-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not application.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors read and approved to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}